US Stock MarketDetailed Quotes

SNDX Syndax Pharmaceuticals

Watchlist
  • 15.885
  • +0.315+2.02%
Trading Feb 27 10:38 ET
1.36BMarket Cap-4.36P/E (TTM)

Syndax Pharmaceuticals Key Stats

Syndax Pharmaceuticals Q4 2024 Estimates Date

Currency:USDMar 3, 2025

Estimate YoY
Revenue
86.51M
--
EPS
-0.82
+17.83%
Strong Buy

Feb 19, 2025

Syndax Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 12.785M--
Mar 3, 20252024/Q4-- / 86.507M--
Nov 5, 20242024/Q312.500M / 8.399M--
Aug 1, 20242024/Q23.500M / 0.000--
May 8, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 12.785M--
Mar 3, 20252024/Q4-- / 86.507M--
Nov 5, 20242024/Q312.500M / 8.399M--
Aug 1, 20242024/Q23.500M / 0.000--
May 8, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Syndax Pharmaceuticals Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 19, 2025

Strong Buy

  • Buy

    90.00%
  • Hold

    10.00%
  • Sell

    0.00%

Price Target

No Data